These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8027366)

  • 1. IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.
    Bansal AS; Abdul-Karim B; Malik RA; Goulding P; Pumphrey RS; Boulton AJ; Holt PL; Wilson PB
    J Clin Pathol; 1994 Apr; 47(4):300-2. PubMed ID: 8027366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA; Wilson R; Prentice RL
    Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
    Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
    Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside.
    Pestronk A; Chuquilin M; Choksi R
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):726-30. PubMed ID: 20581137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of anti-GM1 IgM antibodies.
    Nobile-Orazio E; Carpo M; Scarlato G
    Acta Neurol (Napoli); 1991 Dec; 13(6):514-9. PubMed ID: 1805551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
    Pestronk A; Choksi R; Blume G; Lopate G
    Neurology; 1997 Apr; 48(4):1104-6. PubMed ID: 9109910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity and specificity of anti-GM1 antibody testing.
    Taylor BV; Gross L; Windebank AJ
    Neurology; 1996 Oct; 47(4):951-5. PubMed ID: 8857725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
    Irie S; Saito T; Ogino M; Ito H; Kowa H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease.
    Voumvourakis C; Rombos A; Konstantoulakis MM; Segditsa I; Papageorgiou C
    Acta Neurol Scand; 1992 Dec; 86(6):599-602. PubMed ID: 1481647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
    Yuki N; Watanabe H; Nakajima T; Späth PJ
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):87-91. PubMed ID: 20667861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of neurologic disease associated with anti-GM1 antibodies.
    Sadiq SA; Thomas FP; Kilidireas K; Protopsaltis S; Hays AP; Lee KW; Romas SN; Kumar N; van den Berg L; Santoro M
    Neurology; 1990 Jul; 40(7):1067-72. PubMed ID: 2162499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute motor neuropathy with antibodies to GM1 ganglioside.
    Gregson NA; Jones D; Thomas PK; Willison HJ
    J Neurol; 1991 Dec; 238(8):447-51. PubMed ID: 1779252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro.
    Heidenreich F; Leifeld L; Jovin T
    J Neuroimmunol; 1994 Jan; 49(1-2):97-108. PubMed ID: 8294565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera.
    Adams D; Kuntzer T; Burger D; Chofflon M; Magistris MR; Regli F; Steck AJ
    J Neuroimmunol; 1991 Jun; 32(3):223-30. PubMed ID: 2033117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.